Matthias Weisbrod
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Matthias Weisbrod has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Christine Thomas
Department of Geriatric Psychiatry, Centre of Psychiatry and Psychotherapy, Ev. Hospital Bielefeld-Bethel, Bielefeld, Germany
1 shared publication - Christoph Mundt
University of Heidelberg
1 shared publication - Jürgen Kopitz
Institute of Pathology, University of Heidelberg, Heidelberg, Germany
1 shared publication - Konstanze Plaschke
Department of Anesthesiology, University Hospital Heidelberg, Heidelberg, Germany
1 shared publication - Martin Driessen
Department of Psychiatry and Psychotherapy, University Medical Center OWL, Evangelisches Klinikum Bethel, Bielefeld University, Bielefeld, Germany
1 shared publication - Peter Oster
Bethanien-Hospital, Geriatric Centre of the University of Heidelberg, Rohrbacher Str. 149, 69126, Heidelberg, Germany
1 shared publication
Latest Publications
- Open Access
- 15 September 2008
- Published by Springer Nature in BMC Neuroscience
- Vol. 9 (1) , 86
Serum anticholinergic activity and cerebral cholinergic dysfunction: An EEG study in frail elderly with and without delirium
Delirium increases morbidity, mortality and healthcare costs especially in the elderly. Serum anticholinergic activity (SAA) is a suggested biomarker for anticholinergic burden and delirium risk, but the association with cerebral cholinergic function remains unclear. To clarify this relationship, we prospectively assessed the correlation of SAA with quantitative electroencephalography (qEEG) power, delirium occurrence, functional and cognitive measures in a cross-sectional sample of acutely hospitalized elderly (> 80 y) with high dementia and delirium prevalence.
- 15 September 2008
- Published by Springer Nature in BMC Neuroscience
- Vol. 9 (1) , 86
Open AccessSerum anticholinergic activity and cerebral cholinergic dysfunction: An EEG study in frail elderly with and without delirium
Delirium increases morbidity, mortality and healthcare costs especially in the elderly. Serum anticholinergic activity (SAA) is a suggested biomarker for anticholinergic burden and delirium risk, but the association with cerebral cholinergic function remains unclear. To clarify this relationship, we prospectively assessed the correlation of SAA with quantitative electroencephalography (qEEG) power, delirium occurrence, functional and cognitive measures in a cross-sectional sample of acutely hospitalized elderly (> 80 y) with high dementia and delirium prevalence.